These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1405 related articles for article (PubMed ID: 17890938)

  • 1. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system and its therapeutic exploitation.
    Di Marzo V; Bifulco M; De Petrocellis L
    Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS; Hungund BL
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
    Costa B
    Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
    Bab I; Zimmer A; Melamed E
    Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
    Onaivi ES
    Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid transmission and pain perception.
    Martin BR; Lichtman AH
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):447-61. PubMed ID: 9974177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and gastrointestinal motility: animal and human studies.
    Aviello G; Romano B; Izzo AA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors in atherosclerosis.
    Steffens S; Mach F
    Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.